Big Red launch Air Handling Hygiene & Decontamination Services to combat mycoplasma outbreak

PRLog (Press Release) – Oct 04, 2007 – Air handling unit in building plays an important role in providing comfort in terms of
temperature, humidity and most importantly, filtering biological airborne allergen and dusts particulate.

Avoidance measures, protective and/or mitigation measures have marked therapeutic effect to patients hypersensitive to these allergens. The ability to measure indoor air enables the building occupant or consumer to quantitatively analyze the allergen load, thermal conditions and aerobiology content in an environment.

Understanding temperature, relative humidity, surface particulate, allergen load and
airborne particulate is extremely advantageous to understanding the total environment and imperative to knowing what preventive mitigation measures to prescribe.

Air filters are part of the front-line for dealing with microbial problems in our modern
buildings. Upgrading efficiency of air filters by adding a durable, safe and effective antimicrobial treatment can protect the air filter from abnormal fungal growth and improve the air quality of our buildings. Treatment of Aegis Microbe Shield has shown significant reduction of biological load in the air and the treated surface in the handling room.

Long Term Benefit of AEGIS Microbe Shield

ÆGIS Microbe Shield technology does not dissipate or leach, it can not be absorbed by the organism - or by you. With the ÆGIS Microbe Shield technology, the membrane of the microbe is physically ruptured by a stabbing and electrocution action. Since it is not consumed and does not dissipate, the antimicrobial active is not depleted and continues to control microbial growth over time. This means that the antimicrobial will be fully effective as long as the surface remains intact.


Big Red Environmental provides assessment and consultancy services in the fields of
environmental diagnostics through testing, inspection, bio decontamination and the application of technology with the aim of achieving a safer indoor environmental quality.

For more information on Indoor air quality testing,  please visit http://www.iaqsg.com

Our vast experience, track record and expert resources in the multi discipline areas give you the advantage of a one stop centre. As the market leader in environmental source control and eradication, Aegis Asia has gain an edge in providing solution where other companies have yet to venture.


About Mycoplasma

Mycoplasma is a genus of bacteria that lack cell walls. Because they lack cell walls, they are unaffected by most antibiotics such as penicillin that target cell wall synthesis. They can be parasitic or saprophytic. Several species are pathogenic in humans, including M. pneumoniae, which is an important cause of pneumonia and other respiratory disorders, and M. genitalium, which is believed to be involved in pelvic inflammatory diseases. They may cause or contribute to some cancers.

The genus Mycoplasma is one of several genera within the class Mollicutes. Mollicutes are bacteria which have small genomes, lack a cell wall and have low GC-content (18-40 mol%). There are over 100 recognized species of the genus Mycoplasma. Their genome size ranges from 0.6 - 1.35 megabase-pairs. Mollicutes are parasites or commensals of humans, other animals including insects, and plants; the genus Mycoplasma is by definition restricted to vertebrate hosts. Cholesterol is required for the growth of species of the genus Mycoplasma as well as certain other genera of mollicutes.

Their optimum growth temperature is often the temperature of their host if warmbodied (e.g. 37 degrees Celsius in humans) or ambient temperature if the host is unable to regulate its own internal temperature.

Mycoplasmas are often found in research laboratories as contaminants in cell culture and come from careless handling; due to their small size, they are difficult to detect under a microscope and their presence can skew experimental results.


For more information, Please visit our website: http://www.brenv.com